Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
11
self-reported 2–10 band
Founded
2022
4 years
Legal entities
1
ACRA
Office countries
2
2 addresses
Funding rounds
1
Series A · Oct 2023 · US$ 16.0M
Company type
Privately Held
self-reported
Legal entity
1 brand → 1 confirmed entity
AUTOMERA PTE. LTD.Entity record →
UEN202215767K
Legal entities
Show as table · Automera: 1 registry entity
| AUTOMERA PTE. LTD. | UEN 202215767K |
|---|---|
| Confirmed matches | 1 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Description
Automera is an early-stage company focused on the development of a novel therapeutic approach via autophagy-based targeted protein degradation. Automera aims to leverage its unique understanding of autophagy, drug development capabilities, and access to quantum chemistry and generative AI-enabled insights to enhance its drug development programs. Automera’s AUTAC platform has broad potential across cancer and other disease areas, with oncology being the initial lead program. The company was founded by co-founders Associate Professor Michael Lazarou, Loong Wang, and Taiyang Zhang at Talo Labs Pte Ltd.
Locations
2
Countries with an office address2 addresses on record
SingaporeprimaryUnited States
Country footprint
Show as table · Offices in 2 countries
| Countries | 2 |
|---|---|
| Primary country | SG |
All codes: SG US
Addresses
- SG79 Science Park Drive #04-05, CINTECH IV; Singapore Science Park 1; Singapore, 118264Primary
- US2815 Eastlake Ave E; Suite 300; Seattle, WA 98102
Grid intelligence Members
Funding
Last round · 26 October 2023US$ 16.0MSeries A · investors: ClavystBio, Accelerator Life Science Partners
Rounds1
Round typeSeries A · venture round
Amount (USD)16,000,000
Stage rank3
Investors named2
Since last round2 yr 2 mo
Funding
Show as table · 1 funding round
| Rounds | 1 |
|---|---|
| Axis | 2022 to 2026 |
| Series A · 26 Oct 2023 | US$ 16.0M |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Counts only. No names are stored here, and none are served.
FAQ
Which legal entity operates under Automera?
One Singapore entity on ACRA. AUTOMERA PTE. LTD. (UEN 202215767K), high confidence.
How many people work at Automera?
The record holds 11 counted staff profiles at January 2026, above the self-reported 2–10 band.
Where does Automera have offices?
Two addresses on record across 2 countries. Primary: 79 Science Park Drive #04-05, CINTECH IV, Singapore Science Park 1, Singapore 118264.
Has Automera raised funding?
One round. Latest 26 October 2023: Series A, US$16,000,000, investors ClavystBio and Accelerator Life Science Partners.
Which companies are listed alongside Automera?
6 profiles list Automera as a peer — 68th percentile in Biotechnology Research. It lists ten peers of its own. MediSix Therapeutics and QDX list it back.